what is resolution 5 re objo?, page-50

Hey Surges,
A very detailed reply to my proposal as I have come to expect from you reading your posts.
I really do hope that your reasoning is the actual fact!
I agree it is a fair assumption to infer that because Obj has been dealing with Glaxo for such a long period of time, what is announced by the companies is not always necessarily what has just taken place. There is always some lag time with this information comming to market.
Indeed they may well be quite a way down the track in testing for this particular market product we speak of?
I still am sceptical however as to the rationale behind this whole options deal. Surely its in the companies best interest to have the options converted. If options are in the money, ie solid share price come time for conversion, why offer a scheme to extend the current option? It does not make any sense other than perhaps the directors either;
1. Feel the company share price may fall back a little come option conversion time, or
2. Have lots of options held and do not want to raise the capital to convert at this time.